Skip to main content

Table 2 Analysis of 27 clinical data in pregnancy loss and nonpregnancy loss

From: Autophagy Proteins and clinical data reveal the prognosis of polycystic ovary syndrome

Variable (n)

NON-pregnancy loss (n = 20)

Pregnancy loss (n = 13)

p-value

Age(year)

  

1.00

 < 30

18 (90%)

12 (92%)

 

 > 30

2 (10%)

1 (8%)

 

BMI (kg/m2)

23.3 (3.4)

25.6 (4.0)

0.09

AMH (ng/mL)

9.4 (4.4)

8.2 (3.5)

0.43

FSH (mIU/mL)

6.7 (1.4)

7.0 (2.0)

0.64

LH (mIU/mL)

12.3 (3.5)

11.2 (5.3)

0.47

LH/FSH ratio

1.9 (0.6)

1.6 (0.8)

0.33

T (ng/dL)

42.0 (11.8)

42.2 (24.5)

0.98

FPG (mmol/L)

5.2 (0.6)

5.2 (0.5)

0.81

Insulin (mIU/mL)

16.3 (9.0)

24.5 (16.1)

0.07

HOMA-IR

3.9 (2.3)

5.7 (4.0)

0.10

ET (mm)

4.3 (1.6)

3.5 (1.1)

0.17

T3(nmol/L)

1.8 (0.3)

1.9 (0.2)

0.45

T4(nmol/L)

109.3 (18.2)

119.8 (15.6)

0.10

FT3 (pmol/L)

5.4 (0.5)

5.5 (0.4)

0.71

FT4 (pmol/L)

15.8 (2.0)

15.3 (1.5)

0.47

TSH (uIU/ml)

2.7 (1.2)

3.2 (1.2)

0.28

thyroglobulin (ng/ml)

14.3 (8.5)

23.8 (21.2)

0.08

ATG-AB(U/ml)

  

1.00

 < 35

19 (95%)

12 (92%)

 

 > 35

1 (5%)

1 (8%)

 

TPO-AB(U/ml)

  

0.07

 < 35

12 (60%)

3 (23%)

 

 > 35

8 (40%)

10 (77%)

 

TC (mmol/L)

4.0 (0.8)

4.1 (0.6)

0.73

TG (mmol/L)

1.4 (0.9)

1.6 (0.9)

0.55

HDL(mmol/L)

1.3 (0.3)

1.3 (0.3)

0.82

LDL(mmol/L)

2.6 (0.7)

2.7 (0.7)

0.71

HCY(umol/L)

12.6 (3.5)

12.4 (6.8)

0.89

VD3(ng/L)

10.0 (4.0)

12.3 (5.1)

0.16

D2 polyme(mg/L)

0.6 (1.2)

0.5 (0.6)

0.79

CA125(U/ml)

15.7 (9.8)

16.5 (9.3)

0.83

  1. T3 Triiodothyronine, T4 Thyroxine, TSH Thyroid-stimulating hormone, FT3 Free triiodothyronine, FT4 Free thyroxine, ATG-AB Antithyroglobulin antibody, TPO-AB Thyroid peroxidase antibody, TC Cholesterol, TG Triglyceride, HDL High-density lipoprotein, LDL Low density Lipoprotein, HCY Homocysteine
  2. p < .05 was considered statistically significant